Baxter Total Change in Assets/Liabilities 2010-2025 | BAX

Baxter annual/quarterly total change in assets/liabilities history and growth rate from 2010 to 2025. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
  • Baxter total change in assets/liabilities for the quarter ending March 31, 2025 was $-0.298B, a 78.44% increase year-over-year.
  • Baxter total change in assets/liabilities for the twelve months ending March 31, 2025 was $-1.497B, a 484.83% decline year-over-year.
  • Baxter annual total change in assets/liabilities for 2024 was $-0.236B, a 246.58% decline from 2023.
  • Baxter annual total change in assets/liabilities for 2023 was $0.161B, a 126.57% decline from 2022.
  • Baxter annual total change in assets/liabilities for 2022 was $-0.606B, a 963.16% increase from 2021.
Baxter Annual Total Change in Assets/Liabilities
(Millions of US $)
2024 $-236
2023 $161
2022 $-606
2021 $-57
2020 $-272
2019 $-425
2018 $-248
2017 $-110
2016 $-176
2015 $-339
2014 $-414
2013 $22
2012 $-606
2011 $-693
2010 $-258
2009 $-341
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.529B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.407B 27.95
Boston Scientific (BSX) United States $151.037B 37.81
Stryker (SYK) United States $146.527B 30.64
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $112.146B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.313B 0.00
Haleon (HLN) United Kingdom $49.826B 28.39
ResMed (RMD) United States $36.979B 27.77
Agilent Technologies (A) United States $32.895B 21.44
GE HealthCare Technologies (GEHC) United States $32.794B 15.57
Terumo (TRUMY) Japan $26.561B 34.50
Koninklijke Philips (PHG) Netherlands $22.051B 15.85
Insulet (PODD) United States $21.941B 86.12
Zimmer Biomet Holdings (ZBH) United States $18.277B 11.74
Smith & Nephew SNATS (SNN) United Kingdom $13.253B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Sunny Optical Technology (SNPTF) China $8.430B 0.00
Bio-Rad Laboratories (BIO) United States $5.971B 20.78
Lantheus Holdings (LNTH) United States $5.642B 14.23
Prestige Consumer Healthcare (PBH) United States $4.203B 18.78
Perrigo (PRGO) Ireland $3.596B 9.11
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.385B 15.42
ICU Medical (ICUI) United States $3.275B 24.15
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $1.997B 13.73
LeMaitre Vascular (LMAT) United States $1.901B 42.49
AtriCure (ATRC) United States $1.730B 0.00
Acuren (TIC) United States $1.271B 0.00
AdaptHealth (AHCO) United States $1.201B 12.19
Neogen (NEOG) United States $1.131B 14.47
BioLife Solutions (BLFS) United States $1.126B 0.00
Green Thumb Industries (GTBIF) United States $1.100B 24.74
Kestra Medical Technologies (KMTS) United States $1.063B 0.00
Phibro Animal Health (PAHC) United States $0.976B 12.48
InMode (INMD) Israel $0.895B 9.02
Capricor Therapeutics (CAPR) United States $0.650B 0.00
Evolus (EOLS) United States $0.647B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Owens & Minor (OMI) United States $0.619B 5.13
Maravai LifeSciences Holdings (MRVI) United States $0.609B 0.00
Curaleaf Holdings (CURLF) Canada $0.584B 0.00
Valneva SE (VALN) France $0.524B 0.00
Surmodics (SRDX) United States $0.420B 0.00
Tilray Brands (TLRY) Canada $0.408B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.76
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.322B 57.20
Canopy Growth (CGC) Canada $0.313B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.289B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Cresco Labs (CRLBF) United States $0.265B 0.00
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 11.87
Sanuwave Health (SNWV) United States $0.239B 0.00
Omeros (OMER) United States $0.221B 0.00
OraSure Technologies (OSUR) United States $0.216B 0.00
Biote (BTMD) United States $0.210B 5.89
Quanterix (QTRX) United States $0.209B 0.00
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Brainsway (BWAY) Israel $0.197B 52.25
High Tide (HITI) Canada $0.193B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.86
Organigram Global (OGI) Canada $0.181B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Jin Medical (ZJYL) China $0.120B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.59
Quipt Home Medical (QIPT) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.082B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.038B 13.14
Nephros (NEPH) United States $0.036B 48.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00